Provided by Tiger Trade Technology Pte. Ltd.

Avadel Pharmaceuticals plc

21.64
0.0000
Volume:- -
Turnover:- -
Market Cap:2.12B
PE:-7.53K
High:21.64
Open:21.64
Low:21.64
Close:21.64
52wk High:23.57
52wk Low:6.38
Shares:98.15M
Float Shares:80.64M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0029
EPS(LYR):-0.5133
ROE:-0.32%
ROA:-0.34%
PB:21.62
PE(LYR):-42.16

Loading ...

Company Profile

Company Name:
Avadel Pharmaceuticals plc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.